When: June 13 & 14 2024
Where: South Street Landing Conference Center, Providence, Rhode Island

Organizers:
Annie De Groot & Rich-Henry Schabowsky, EpiVax, Inc. 
Joan Peckham, University of Rhode Island
Tom Sgouros, Brown University
Jason Machan, Lifespan

Purpose: This event aims to facilitate discussions and knowledge sharing among users of bioinformatics and immunoinformatics tools. Speakers will describe tools used for the exploration of immune responses and provide case studies featuring applications to biologic drugs and vaccines, and assessment of (biologic and peptide) drug safety and immunogenicity. 

Who should attend: The event is tailored for professionals and researchers utilizing bioinformatics and immunoinformatics tools, particularly those involved in studying infectious diseases, immune responses, vaccine development, and drug safety. Participants will have the opportunity to delve into emerging trends and foster collaborations in the rapidly evolving fields of immunoinformatics, computational vaccinology and biologics immuno-engineering.
Find more information about the event here.

*Please note: This is an in-person event with no option for virtual attendance*

Save your seat by registering below!


Speakers will include:
Annie De Groot MD, Co-founder & CSO, EpiVax Inc.
Tom Sgouros, Research Associate, Brown University
Joan Peckham, PhD, Professor Emeritus, University of Rhode Island
Kimberly VanderWaal, PhD, Associate Professor, University of Minnesota
Justin Bahl, PhD, Professor, University of Georgia
Mark Kon, PhD, Professor, Boston University
Guilhem Richard, PhD, CSO & CTO, EpiVax Therapeutics
Sohini Ramachandran, PhD, Director of the Data Science Institute, Brown University
Amy Rosenberg, MD, Sr. Director of Immunology & Protein Therapeutics, EpiVax (Formerly FDA)
Brandon DeKosky, PhD, The Broad Institute of MIT and Harvard University
Christopher Langmead, PhD, Executive Director, Amgen
Ewa Lis, PhD, Founder / CEO, Koliber Bio
Jeonghoon Sun, PhD, Founder / CEO, Multiverse Pharma
Aimee Mattei, MS, Director of Immunoinformatics, EpiVax Inc.
Andres Gutierrez, PhD, Sr. Computational Immunologist, EpiVax Inc. 

With more to be announced! 

* indicates required
Do you or your company use EpiVax's immunogenicity assessment software; ISPRI?